Wired Herald

In-Vitro Fertilization (IVF) Market is Heading Up 38.7 Bn $ By 2026

Press release   •   Jul 29, 2019 04:23 EDT

The Global In-Vitro Fertilization (IVF) Market Size is projected to reach US$ 38.7 billion up to 2026, According to a new research report by Acumen Research and Consulting. The market is anticipated to register a CAGR of 9.8% from 2018 - 2026.

Acumen Research and Consulting has recently published a research report on the In-Vitro Fertilization (IVF) Market for the forecast period of 2018 to 2026, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the In-Vitro Fertilization (IVF) Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2026.

The research study on the In-Vitro Fertilization (IVF) Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market. The research study not only focuses on the latent opportunities for the key stakeholders of the market, but also sheds light on the notable developments and future scope for innovation in the landscape.

The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study by ARC on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the In-Vitro Fertilization (IVF) Market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1278

The report also analyzes the In-Vitro Fertilization (IVF) Market on the basis of various segments, with drug type being a prominent one. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Market Segmentation

Market by Instrument

  • Culture Media
  • Disposable Devices
  • Capital Equipment

Market by Type

  • Frozen Non-donor
  • Fresh Non-donor
  • Frozen Donor
  • Fresh Donor

Market by End-Use

  • Fertility Clinics
  • Hospitals & others

Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

The report on the In-Vitro Fertilization (IVF) Market is based on an extensive and meticulous bottom up approach, which was used to determine the market size.

In the primary phase of the research methodology focus on, key stakeholders, including CEOs, presidents, vice presidents, chief medical officers, and product/sales/marketing managers were interviewed for the purpose of garnering unique insights into the dynamics of the market.

Market Participants:

The In-Vitro Fertilization (IVF) market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are EMD Serono Inc.; OvaScience; Genea Biomedx; Vitrolife AB; Irvine Scientific; Thermo Fisher Scientific Inc.; Cook Medical Inc.; Cooper Surgical Inc.; Boston IVF, and Progyny, Inc.

TABLE OF CONTENT

CHAPTER 1. Industry Overview

1.1. Definition and Scope
1.1.1. Definition of In-Vitro Fertilization (IVF)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. In-Vitro Fertilization (IVF) Market By Instrument
1.2.2.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By Instrument (2015-2026)
1.2.2.2. Global In-Vitro Fertilization (IVF) Market Revenue Share By Instrument in 2017
1.2.2.3. Culture Media
1.2.2.4. Disposable Devices
1.2.2.5. Capital Equipment
1.2.2.6. Others
1.2.3. In-Vitro Fertilization (IVF) Market By Type
1.2.3.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.3.2. Frozen Non-donor
1.2.3.3. Fresh Non-donor
1.2.3.4. Frozen Donor
1.2.3.5. Fresh Donor
1.2.3.6. Others
1.2.4. In-Vitro Fertilization (IVF) Market By End Users
1.2.4.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Fertility Clinics
1.2.4.3. Hospitals
1.2.4.4. Others
1.2.5. In-Vitro Fertilization (IVF) Market by Geography
1.2.5.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. Market Dynamics And Competition Analysis

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. Manufacturing Plants Analysis

3.1. Capacity and Commercial Production Date of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017

CHAPTER 4. In-Vitro Fertilization (IVF) Market By Instrument

4.1. Global In-Vitro Fertilization (IVF) Revenue By Instrument
4.2. Culture Media
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Disposable Devices
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Capital Equipment
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Other
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. In-Vitro Fertilization (IVF) Market By Type

5.1. Global In-Vitro Fertilization (IVF) Revenue By Type
5.2. Frozen Non-donor
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Fresh Non-donor
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Frozen Donor
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Fresh Donor
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. In-Vitro Fertilization (IVF) Market By End Users

6.1. Global In-Vitro Fertilization (IVF) Revenue By End Users
6.2. Fertility Clinics
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Hospitals
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. North America In-Vitro Fertilization (IVF) Market By Country

7.1. North America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. In-Vitro Fertilization (IVF) Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. Europe In-Vitro Fertilization (IVF) Market By Country

8.1. Europe In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. Asia-Pacific In-Vitro Fertilization (IVF) Market By Country

9.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. Latin America In-Vitro Fertilization (IVF) Market By Country 

10.1. Latin America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. Middle East In-Vitro Fertilization (IVF) Market By Country 

11.1. Middle East In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. Africa In-Vitro Fertilization (IVF) Market By Country 

12.1. Africa In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. Company Profile

13.1. EMD Serono Inc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. OvaScience
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Genea Biomedx
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Vitrolife AB
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Irvine Scientific
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Thermo Fisher Scientific Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Cook Medical Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Cooper Surgical Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Boston IVF
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Progyny, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies

CHAPTER 14. Research Approach

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1278

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.